Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 943 across all filing types
Latest filing 2025-09-25 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing about the closure of the trading window pursuant to the company's Insider Trading Code. It mentions the upcoming declaration of financial results for the quarter and half year ended September 30, 2025, but does not contain any financial data or results itself. The document is an announcement related to trading restrictions ahead of financial results disclosure, not a financial report or detailed filing. The length is only 1190 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance notices that do not fit other categories.
2025-09-25 English
General Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges reporting the outcome of a Board Meeting under Regulation 30 of SEBI Listing Regulations. It details changes in the roles and responsibilities of senior executives, including redesignations of the Vice Chairman & CEO and Vice Chairman & Managing Director, effective April 1, 2026. There is no financial data, earnings information, or report attached. The content focuses on management changes and organizational structure updates. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3079 characters, which is short and consistent with an announcement rather than a full report.
2025-09-23 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding a request related to physical shares. It references Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, and mentions an enclosed newspaper advertisement about a special window for re-lodgement of transfer requests of physical shares. The content is an announcement informing the exchanges about the publication of a newspaper advertisement and is intended for information and records. There is no substantive financial data, financial statements, or detailed report content. The document is relatively short and serves as a notification rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2025-09-23 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and NSE India) regarding an advertisement published in newspapers about a corrigendum to a Postal Ballot Notice. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The content is about the publication of an advertisement correcting or amending a previously issued Postal Ballot Notice, which is a shareholder voting process. There is no substantive financial data, financial statements, or detailed report content. The document is essentially an announcement or notification of the advertisement publication for regulatory compliance purposes. It is not the Postal Ballot Notice itself, nor the voting results, nor a management or financial report. Given the nature of the document as a regulatory announcement related to shareholder meeting materials, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-18 English
Updates
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice related to a Postal Ballot for shareholders of Neuland Laboratories Limited. It includes a corrigendum to a previously issued Postal Ballot Notice, clarifying a typographical error in the term of appointment of an Independent Director. The document references the Companies Act, SEBI Listing Regulations, and provides detailed procedural information about the e-voting process, the resolution to be passed, and the appointment of the director. It is not a report of voting results but the notice and explanatory statement for the postal ballot itself. This type of document is used to solicit shareholder votes on specific resolutions outside of a general meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or ballots.
2025-09-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of participation in investor meetings, not a financial report, earnings release, or detailed presentation. The document length is short (1478 characters), and it does not contain financial data or detailed analysis. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investor relations activities and disclosures about meetings with analysts and investors.
2025-09-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.